Popular Articles

Biomarkers Predict Brain Tumor's Response To Therapy
A report in Cancer Research, a journal of the American Association for Cancer Research, highlights a new biomarker that may be useful in identifying patients with recurrent glioblastoma, or brain tumors, who would respond better to anti-vascular endothelial growth factor therapy, specifically cediranib.
generic viagra online
Cobalis Corporation Is Awarded Two New International Patents In Canada And Mexico For Its Revolutionary Anti-Allergy Relief Product PreHistin(R)
Cobalis Corporation (OTC:CLSC) was recently awarded two additional International Patents in Canada and Mexico and has a patent pending application in Japan. PreHistin® is patented, safe for long-term daily use and available without a prescription. It is available in a cherry flavored, all natural, proprietary cyanocobalamin (vitamin B12) sub-lingual lozenge that is taken twice daily to regulate allergy sufferers" response to both indoor and outdoor allergens with daily and year round usage.
News of the day
Potential Patient Safety Risks Among Methadone Maintenance Treatment Patients Identified By Researchers
Boston Medical Center (BMC) researchers have identified potential safety risks among methadone maintenance treatment (MMT) patients due to the quantity and accuracy of medical record documentation. Improved communication and coordination among substance use treatment and medical providers could mitigate and manage the potential adverse effects of methadone and interacting medications. The BMC study appears in the July issue of Journal of General Internal Medicine.
Cardiovascular

Radiology Informatics: Frost & Sullivan Examines The Next Big Wave In Medicine

In order to increase productivity, healthcare providers have started to integrate many IT-based ancillary systems such as EMR, HIS and PACS. So far, this has purely been a service-oriented business, in which IT systems have accelerated healthcare practices. However, the lack of qualified staff, such as technologists, physicians and radiologists is creating a challenge for hospitals. A huge number of radiological examinations and the interpretation of images has to take place, and many hospitals are outsourcing this work to speed up productivity. Radiology Informatics will help to eliminate this problem. Unlike other service-based ancillary systems, Radiology Informatics is an artificial intelligence system that will interpret images generated by various imaging modalities. Its aim is to assist radiologists in arriving at a quicker interpretation and also contribute towards recommending other necessary actions for concomitant requirements. Reporting errors, wrong interpretations, and patient report delays due to an unavailability of radiologists will eventually be eliminated. The Healthcare Group at Frost & Sullivan will therefore focus its 2009 Quarterly Analyst Briefing Presentation on the global market for Radiology Informatics. The briefing will be held on Wednesday, 5th August 2009, at 2 p.m. GMT. "The market for Radiology Informatics is in its nascent stage, requiring extensive research backed by funding," says Frost & Sullivan Research Analyst Shriram Shanmugham. "These systems represent the future though." This briefing presentation will be of significant value to venture capitalists and healthcare IT companies looking to expand its product portfolio through innovation. CEOs, corporate vice-presidents for product development, research directors and clinical research managers will benefit from this presentation, as well as professors and post-doctoral students in biomedical and computer engineering. To participate in this briefing, please email Patrick Cairns at patrick.cairns@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be emailed to you. Frost & Sullivan


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):